本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cognition Therapeutics, Inc

0.8400
-0.0216-2.51%
盘后0.84000.00000.00%19:58 EDT
成交量:329.60万
成交额:271.58万
市值:5,207.42万
市盈率:-1.16
高:0.8614
开:0.8600
低:0.7900
收:0.8616
数据加载中...
2022/02/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/10

重要事件披露

8-K - Current report
2021/11/18

重要事件披露

8-K - Current report
2021/11/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/11/03

重要事件披露

8-K - Current report
2021/11/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/14

重要事件披露

8-K - Current report
2021/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/20

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/29

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/07/19

SEC问询函

CORRESP [Cover] - Correspondence